Abstract
With rapid progression of computing and other technological advances, the practice of modern medicine has moved from primarily anecdotal to largely quantitative. With due credit to the Internet and the new cyber-society, individuals have taken a more active role in the decision-making process concerning their health, from deciding whether or not to get screened for a disease to which treatment is best for their specific clinical profile. Treating physicians are more connected with latest medical breakthroughs through vast dissemination via the Internet. Statistical prediction models assembled on large well-designed cohorts, multiply validated and easily accessible through online calculators play a role in translating basic science results to implementation in the community for public health benefit. This chapter describes the risk model building process that forms the basis of modern medical decision-making, from statistical estimation to validation and implementation on the Internet. The early diagnosis of cancer is used as the context to illustrate principles, though the concepts immediately transcend to other disciplines as concluding examples in forestry and finance will show.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Selected Bibliography
H. Akaike, A new look at the statistical model identification. IEEE Trans. Autom. Control 19, 716–723 (1974)
D.P. Ankerst, J. Groskopf, J.R. Day et al., Predicting prostate cancer risk through incorporation of prostate cancer gene 3. J. Urol. 180, 1303–1308 (2008)
D.P. Ankerst, T. Koniarski, Y. Liang et al., Updating risk prediction tools: a case study in prostate cancer. Biom. J. 54, 127–142 (2012)
C.B. Begg, R.A. Greenes, Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 39, 207–215 (1983)
V. Cavadas, L. Osório, F. Sabell, F. Teves, F. Branco, M. Silva-Ramos, Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort. Eur. Urol. 58, 551–558 (2010)
D.R. Cox, Two further applications of a model for binary regression. Biometrika 45, 562–565 (1958)
S.J. Eyre, D.P. Ankerst, J.T. Wei et al., Validation in a multiple urology practice setting of the prostate cancer prevention trial calculator for predicting prostate cancer detection. J. Urol. 182, 2653–2658 (2009)
D.J. Hernandez, M. Han, E.B. Humphreys et al., Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level alone. BJU Int. 103, 609–614 (2009)
K.J.M. Janssen, A.R.T. Donders, F.E. Harrell Jr. et al., Missing covariate data in medical research: to impute is better than to ignore. J. Clin. Epidemiol. 63, 721–727 (2010)
A. Jemal, R. Siegel, J. Xu, E. Ward, Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010)
S. Lemeshow, D.W. Hosmer Jr., A review of goodness of fit statistics for use in the development of logistic regression models. Am. J. Epidemiol. 115, 92–106 (1982)
Y. Liang, D.P. Ankerst, M. Sanchez, R.J. Leach, I.M. Thompson, Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening. Urology 76, 1268.e1–1268.e6 (2010)
M.E. Mille, S.L. Hui, W.M. Tierney, Validation techniques for logistic regression models. Stat. Med. 10, 1213–1226 (1991)
N.J. Nagelkerke, A note on a general definition of the coefficient of determination. Biometrika 78, 691–692 (1991)
C.T. Nguyen, C. Yu, A. Moussa, M.W. Kattan, J.S. Jones, Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy. J. Urol. 183, 529–533 (2010)
D.J. Parekh, D.P. Ankerst, B.A. Higgins et al., External validation of the prostate cancer prevention trial risk calculator in a screened population. Urology 68, 1153–1155 (2006)
M.J. Pencina, R.B. D’Agostino Sr., R.B. D’Agostino Jr., R.S. Vasan, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157–172 (2008)
S. Perdonà, V. Cavadas, G.D. Lorenzo et al., Prostate cancer detection in the grey area of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun’s nomogram, two risk estimators incorporating prostate cancer antigen 3. Eur. Urol. 59, e1–e4 (2011)
G. Schwarz, Estimating the dimension of a model. Ann. Stat. 6, 461–464 (1978)
E.W. Steyerberg, Clinical Prediction Models (Springer, New York, 2010)
E.W. Steyerberg, A.J. Vickers, N.R. Cook et al., Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21, 128–138 (2010)
J.A. Swets, R.M. Pickett, Evaluation of Diagnostic Systems: methods from Signal Detection Theory (Academic Press, New York, 1982)
I.M. Thompson, D.P. Ankerst, C. Chi et al., The operating characteristics of prostate-specific antigen in a population with initial PSA of 3.0 ng/ml or lower. JAMA 294, 66–70 (2005)
I.M. Thompson, D.P. Ankerst, C. Chi et al., Assessing prostate cancer risk: results from the prostate cancer prevention trial. J. Natl. Cancer Inst. 98, 529–534 (2006)
I.M. Thompson, D.P. Ankerst, C. Chi et al., Prediction of prostate cancer for patients receiving finasteride: results from the prostate cancer prevention trial. J. Clin. Oncol. 25, 3076–3081 (2007)
S. van Buuren, Multiple imputation of discrete and continuous data by fully conditional specification. Stat. Methods Med. Res. 16, 219–242 (2007)
A.J. Vickers, E.B. Elkin, Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Mak. 26, 565–574 (2006)
J.F. Yates, External correspondence: decomposition of the mean probability score. Organ. Behav. Hum. Perform. 30, 132–156 (1982)
Additional Literature
D.P. Ankerst, J. Groskopf, J.R. Day et al., Predicting prostate cancer risk through incorporation of prostate cancer gene 3. J. Urol. 180, 1303–1308 (2008)
D.P. Ankerst, T. Koniarski, Y. Liang et al., Updating risk prediction tools: a case study in prostate cancer. Biom. J. 54, 127–142 (2012)
A. Boeck, J. Dieler, P. Biber, H. Pretzsch, D.P. Ankerst, Predicting tree mortality for European beech in southern Germany using spatially-explicit competition indices. For. Sci. (in press)
H. Pretzsch, P. Biber, J. Dursky, The single tree-based stand simulator SILVA: construction, application and evaluation. For. Ecol. Manag. 162, 3–21 (2002)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ankerst, D.P., Seifert-Klauss, V., Kiechle, M. (2014). Translational Risk Models. In: Klüppelberg, C., Straub, D., Welpe, I. (eds) Risk - A Multidisciplinary Introduction. Springer, Cham. https://doi.org/10.1007/978-3-319-04486-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-04486-6_16
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04485-9
Online ISBN: 978-3-319-04486-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)